PURE BioMedicine Q4 2025 Financial Report
PURE BioMedicine Co., Ltd. reported an operating revenue of 31 million NTD and a net loss of 453 million NTD for Q4 2025, resulting in a basic EPS of -7.23 NTD.
📋 Article Processing Timeline
- 📰 Published: December 1, 2025 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (3047h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:21 (16h 21m after Collected)
Company Code: 6949 Company Name: PURE BioMedicine Co., Ltd. Industry: Biotechnology and Medical Industry Year/Quarter: 2025 Q4 Basic Earnings Per Share: -7.23 NTD Operating Revenue: 31 million NTD Net Income After Tax: -453 million NTD